nodes	percent_of_prediction	percent_of_DWPC	metapath
Nedocromil—asthma—chronic obstructive pulmonary disease	0.56	1	CtDrD
Nedocromil—CYSLTR1—Montelukast—chronic obstructive pulmonary disease	0.29	1	CbGbCtD
Nedocromil—CYSLTR2—respiratory system—chronic obstructive pulmonary disease	0.00512	0.164	CbGeAlD
Nedocromil—FPR1—respiratory system—chronic obstructive pulmonary disease	0.00461	0.147	CbGeAlD
Nedocromil—Pulmonary eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.00275	0.0418	CcSEcCtD
Nedocromil—CYSLTR2—lung—chronic obstructive pulmonary disease	0.00272	0.0869	CbGeAlD
Nedocromil—FPR1—lung—chronic obstructive pulmonary disease	0.00245	0.0782	CbGeAlD
Nedocromil—PTGDR—lung—chronic obstructive pulmonary disease	0.00231	0.0739	CbGeAlD
Nedocromil—Sputum increased—Arformoterol—chronic obstructive pulmonary disease	0.00197	0.0299	CcSEcCtD
Nedocromil—Sputum increased—Formoterol—chronic obstructive pulmonary disease	0.00197	0.0299	CcSEcCtD
Nedocromil—CYSLTR1—respiratory system—chronic obstructive pulmonary disease	0.00193	0.0616	CbGeAlD
Nedocromil—Increased bronchial secretion—Formoterol—chronic obstructive pulmonary disease	0.00185	0.0281	CcSEcCtD
Nedocromil—Increased bronchial secretion—Arformoterol—chronic obstructive pulmonary disease	0.00185	0.0281	CcSEcCtD
Nedocromil—Sensation of warmth—Salbutamol—chronic obstructive pulmonary disease	0.0018	0.0274	CcSEcCtD
Nedocromil—HSP90AA1—respiratory system—chronic obstructive pulmonary disease	0.00167	0.0534	CbGeAlD
Nedocromil—CYSLTR1—bronchus—chronic obstructive pulmonary disease	0.00159	0.0507	CbGeAlD
Nedocromil—CYSLTR1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00155	0.0496	CbGeAlD
Nedocromil—HSP90AA1—connective tissue—chronic obstructive pulmonary disease	0.00147	0.047	CbGeAlD
Nedocromil—HSP90AA1—bronchus—chronic obstructive pulmonary disease	0.00138	0.044	CbGeAlD
Nedocromil—HSP90AA1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00135	0.043	CbGeAlD
Nedocromil—Disorder sight—Tiotropium—chronic obstructive pulmonary disease	0.00134	0.0203	CcSEcCtD
Nedocromil—HSP90AA1—trachea—chronic obstructive pulmonary disease	0.00124	0.0395	CbGeAlD
Nedocromil—CYSLTR1—lung—chronic obstructive pulmonary disease	0.00102	0.0327	CbGeAlD
Nedocromil—HSP90AA1—lung—chronic obstructive pulmonary disease	0.000888	0.0284	CbGeAlD
Nedocromil—Dysphonia—Tiotropium—chronic obstructive pulmonary disease	0.000773	0.0118	CcSEcCtD
Nedocromil—Otitis media—Montelukast—chronic obstructive pulmonary disease	0.000646	0.00982	CcSEcCtD
Nedocromil—Influenza—Roflumilast—chronic obstructive pulmonary disease	0.000634	0.00965	CcSEcCtD
Nedocromil—Dysphonia—Formoterol—chronic obstructive pulmonary disease	0.000624	0.00948	CcSEcCtD
Nedocromil—Dysphonia—Arformoterol—chronic obstructive pulmonary disease	0.000624	0.00948	CcSEcCtD
Nedocromil—Otitis media—Salbutamol—chronic obstructive pulmonary disease	0.000622	0.00946	CcSEcCtD
Nedocromil—Feeling hot—Salbutamol—chronic obstructive pulmonary disease	0.000617	0.00939	CcSEcCtD
Nedocromil—Dysphonia—Salbutamol—chronic obstructive pulmonary disease	0.000589	0.00895	CcSEcCtD
Nedocromil—Pneumonia—Roflumilast—chronic obstructive pulmonary disease	0.000569	0.00865	CcSEcCtD
Nedocromil—Viral infection—Formoterol—chronic obstructive pulmonary disease	0.000568	0.00864	CcSEcCtD
Nedocromil—Viral infection—Arformoterol—chronic obstructive pulmonary disease	0.000568	0.00864	CcSEcCtD
Nedocromil—Viral infection—Montelukast—chronic obstructive pulmonary disease	0.000556	0.00846	CcSEcCtD
Nedocromil—Viral infection—Salbutamol—chronic obstructive pulmonary disease	0.000536	0.00816	CcSEcCtD
Nedocromil—Sinusitis—Roflumilast—chronic obstructive pulmonary disease	0.000531	0.00807	CcSEcCtD
Nedocromil—Cough increased—Salbutamol—chronic obstructive pulmonary disease	0.000529	0.00805	CcSEcCtD
Nedocromil—Rhinitis—Roflumilast—chronic obstructive pulmonary disease	0.000509	0.00774	CcSEcCtD
Nedocromil—Arthritis—Tiotropium—chronic obstructive pulmonary disease	0.000475	0.00722	CcSEcCtD
Nedocromil—Dysgeusia—Roflumilast—chronic obstructive pulmonary disease	0.000433	0.00658	CcSEcCtD
Nedocromil—Ear pain—Montelukast—chronic obstructive pulmonary disease	0.000428	0.0065	CcSEcCtD
Nedocromil—Gastroenteritis—Formoterol—chronic obstructive pulmonary disease	0.00042	0.00639	CcSEcCtD
Nedocromil—Gastroenteritis—Arformoterol—chronic obstructive pulmonary disease	0.00042	0.00639	CcSEcCtD
Nedocromil—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.000414	0.0063	CcSEcCtD
Nedocromil—Ear pain—Salbutamol—chronic obstructive pulmonary disease	0.000412	0.00627	CcSEcCtD
Nedocromil—Gastroenteritis—Montelukast—chronic obstructive pulmonary disease	0.000412	0.00626	CcSEcCtD
Nedocromil—Nasal congestion—Arformoterol—chronic obstructive pulmonary disease	0.000409	0.00622	CcSEcCtD
Nedocromil—Nasal congestion—Formoterol—chronic obstructive pulmonary disease	0.000409	0.00622	CcSEcCtD
Nedocromil—Eczema—Montelukast—chronic obstructive pulmonary disease	0.000406	0.00617	CcSEcCtD
Nedocromil—Gastroenteritis—Salbutamol—chronic obstructive pulmonary disease	0.000397	0.00603	CcSEcCtD
Nedocromil—Eczema—Salbutamol—chronic obstructive pulmonary disease	0.000391	0.00595	CcSEcCtD
Nedocromil—Nasal congestion—Salbutamol—chronic obstructive pulmonary disease	0.000386	0.00587	CcSEcCtD
Nedocromil—Arthritis—Formoterol—chronic obstructive pulmonary disease	0.000383	0.00583	CcSEcCtD
Nedocromil—Arthritis—Arformoterol—chronic obstructive pulmonary disease	0.000383	0.00583	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Tiotropium—chronic obstructive pulmonary disease	0.000371	0.00564	CcSEcCtD
Nedocromil—Stinging—Prednisolone—chronic obstructive pulmonary disease	0.000343	0.00522	CcSEcCtD
Nedocromil—Sinusitis—Tiotropium—chronic obstructive pulmonary disease	0.000334	0.00507	CcSEcCtD
Nedocromil—Influenza—Formoterol—chronic obstructive pulmonary disease	0.000322	0.0049	CcSEcCtD
Nedocromil—Influenza—Arformoterol—chronic obstructive pulmonary disease	0.000322	0.0049	CcSEcCtD
Nedocromil—Rhinitis—Tiotropium—chronic obstructive pulmonary disease	0.00032	0.00487	CcSEcCtD
Nedocromil—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.000318	0.00483	CcSEcCtD
Nedocromil—Pharyngitis—Tiotropium—chronic obstructive pulmonary disease	0.000317	0.00482	CcSEcCtD
Nedocromil—Influenza—Montelukast—chronic obstructive pulmonary disease	0.000315	0.00479	CcSEcCtD
Nedocromil—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.000312	0.00475	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000311	0.00474	CcSEcCtD
Nedocromil—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.000311	0.00473	CcSEcCtD
Nedocromil—Bronchitis—Arformoterol—chronic obstructive pulmonary disease	0.00031	0.00471	CcSEcCtD
Nedocromil—Bronchitis—Formoterol—chronic obstructive pulmonary disease	0.00031	0.00471	CcSEcCtD
Nedocromil—Visual impairment—Tiotropium—chronic obstructive pulmonary disease	0.000308	0.00468	CcSEcCtD
Nedocromil—Viral infection—Prednisolone—chronic obstructive pulmonary disease	0.000308	0.00468	CcSEcCtD
Nedocromil—Influenza—Salbutamol—chronic obstructive pulmonary disease	0.000304	0.00462	CcSEcCtD
Nedocromil—Bronchitis—Montelukast—chronic obstructive pulmonary disease	0.000303	0.00461	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Formoterol—chronic obstructive pulmonary disease	0.000299	0.00455	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Arformoterol—chronic obstructive pulmonary disease	0.000299	0.00455	CcSEcCtD
Nedocromil—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.000295	0.00449	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Montelukast—chronic obstructive pulmonary disease	0.000293	0.00446	CcSEcCtD
Nedocromil—Bronchitis—Salbutamol—chronic obstructive pulmonary disease	0.000292	0.00445	CcSEcCtD
Nedocromil—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000287	0.00436	CcSEcCtD
Nedocromil—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000285	0.00434	CcSEcCtD
Nedocromil—Pneumonia—Montelukast—chronic obstructive pulmonary disease	0.000283	0.0043	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Salbutamol—chronic obstructive pulmonary disease	0.000283	0.0043	CcSEcCtD
Nedocromil—Conjunctivitis—Arformoterol—chronic obstructive pulmonary disease	0.000279	0.00424	CcSEcCtD
Nedocromil—Conjunctivitis—Formoterol—chronic obstructive pulmonary disease	0.000279	0.00424	CcSEcCtD
Nedocromil—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.000276	0.0042	CcSEcCtD
Nedocromil—Conjunctivitis—Montelukast—chronic obstructive pulmonary disease	0.000273	0.00416	CcSEcCtD
Nedocromil—Sinusitis—Formoterol—chronic obstructive pulmonary disease	0.000269	0.00409	CcSEcCtD
Nedocromil—Sinusitis—Arformoterol—chronic obstructive pulmonary disease	0.000269	0.00409	CcSEcCtD
Nedocromil—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000266	0.00404	CcSEcCtD
Nedocromil—Sinusitis—Montelukast—chronic obstructive pulmonary disease	0.000264	0.00401	CcSEcCtD
Nedocromil—Conjunctivitis—Salbutamol—chronic obstructive pulmonary disease	0.000263	0.00401	CcSEcCtD
Nedocromil—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000259	0.00394	CcSEcCtD
Nedocromil—Rhinitis—Arformoterol—chronic obstructive pulmonary disease	0.000258	0.00393	CcSEcCtD
Nedocromil—Rhinitis—Formoterol—chronic obstructive pulmonary disease	0.000258	0.00393	CcSEcCtD
Nedocromil—Pharyngitis—Formoterol—chronic obstructive pulmonary disease	0.000256	0.00389	CcSEcCtD
Nedocromil—Pharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.000256	0.00389	CcSEcCtD
Nedocromil—Sinusitis—Salbutamol—chronic obstructive pulmonary disease	0.000254	0.00387	CcSEcCtD
Nedocromil—Rhinitis—Montelukast—chronic obstructive pulmonary disease	0.000253	0.00385	CcSEcCtD
Nedocromil—Pharyngitis—Montelukast—chronic obstructive pulmonary disease	0.000251	0.00381	CcSEcCtD
Nedocromil—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.000248	0.00378	CcSEcCtD
Nedocromil—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.000248	0.00378	CcSEcCtD
Nedocromil—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000247	0.00375	CcSEcCtD
Nedocromil—Rhinitis—Salbutamol—chronic obstructive pulmonary disease	0.000244	0.00371	CcSEcCtD
Nedocromil—Cough—Tiotropium—chronic obstructive pulmonary disease	0.000243	0.00369	CcSEcCtD
Nedocromil—Pharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.000241	0.00367	CcSEcCtD
Nedocromil—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000241	0.00366	CcSEcCtD
Nedocromil—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000239	0.00363	CcSEcCtD
Nedocromil—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000237	0.0036	CcSEcCtD
Nedocromil—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000231	0.00352	CcSEcCtD
Nedocromil—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000229	0.00349	CcSEcCtD
Nedocromil—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000227	0.00346	CcSEcCtD
Nedocromil—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000227	0.00346	CcSEcCtD
Nedocromil—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000226	0.00344	CcSEcCtD
Nedocromil—Viral infection—Prednisone—chronic obstructive pulmonary disease	0.000224	0.0034	CcSEcCtD
Nedocromil—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.00022	0.00334	CcSEcCtD
Nedocromil—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.00022	0.00334	CcSEcCtD
Nedocromil—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000214	0.00326	CcSEcCtD
Nedocromil—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000212	0.00322	CcSEcCtD
Nedocromil—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00021	0.0032	CcSEcCtD
Nedocromil—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00021	0.0032	CcSEcCtD
Nedocromil—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000207	0.00315	CcSEcCtD
Nedocromil—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000206	0.00313	CcSEcCtD
Nedocromil—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.0002	0.00304	CcSEcCtD
Nedocromil—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000198	0.00302	CcSEcCtD
Nedocromil—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000197	0.00299	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000196	0.00298	CcSEcCtD
Nedocromil—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000196	0.00298	CcSEcCtD
Nedocromil—Cough—Formoterol—chronic obstructive pulmonary disease	0.000196	0.00298	CcSEcCtD
Nedocromil—Cough—Montelukast—chronic obstructive pulmonary disease	0.000192	0.00292	CcSEcCtD
Nedocromil—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000191	0.00291	CcSEcCtD
Nedocromil—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000191	0.0029	CcSEcCtD
Nedocromil—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000191	0.0029	CcSEcCtD
Nedocromil—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00019	0.00289	CcSEcCtD
Nedocromil—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00019	0.00289	CcSEcCtD
Nedocromil—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000187	0.00284	CcSEcCtD
Nedocromil—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000187	0.00284	CcSEcCtD
Nedocromil—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000186	0.00282	CcSEcCtD
Nedocromil—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.00281	CcSEcCtD
Nedocromil—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000183	0.00278	CcSEcCtD
Nedocromil—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000183	0.00278	CcSEcCtD
Nedocromil—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00018	0.00274	CcSEcCtD
Nedocromil—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00018	0.00274	CcSEcCtD
Nedocromil—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000179	0.00273	CcSEcCtD
Nedocromil—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000179	0.00273	CcSEcCtD
Nedocromil—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000177	0.00269	CcSEcCtD
Nedocromil—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000176	0.00268	CcSEcCtD
Nedocromil—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000173	0.00263	CcSEcCtD
Nedocromil—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000167	0.00254	CcSEcCtD
Nedocromil—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000165	0.0025	CcSEcCtD
Nedocromil—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000163	0.00248	CcSEcCtD
Nedocromil—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000163	0.00248	CcSEcCtD
Nedocromil—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000161	0.00245	CcSEcCtD
Nedocromil—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000161	0.00245	CcSEcCtD
Nedocromil—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000159	0.00242	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000158	0.0024	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000158	0.0024	CcSEcCtD
Nedocromil—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000158	0.0024	CcSEcCtD
Nedocromil—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000158	0.0024	CcSEcCtD
Nedocromil—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000158	0.0024	CcSEcCtD
Nedocromil—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000157	0.00238	CcSEcCtD
Nedocromil—Pain—Formoterol—chronic obstructive pulmonary disease	0.000157	0.00238	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000155	0.00235	CcSEcCtD
Nedocromil—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000155	0.00235	CcSEcCtD
Nedocromil—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000154	0.00234	CcSEcCtD
Nedocromil—Pain—Montelukast—chronic obstructive pulmonary disease	0.000153	0.00233	CcSEcCtD
Nedocromil—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000153	0.00233	CcSEcCtD
Nedocromil—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.00231	CcSEcCtD
Nedocromil—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000152	0.00231	CcSEcCtD
Nedocromil—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000152	0.0023	CcSEcCtD
Nedocromil—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000151	0.0023	CcSEcCtD
Nedocromil—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000151	0.00229	CcSEcCtD
Nedocromil—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00015	0.00228	CcSEcCtD
Nedocromil—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00015	0.00228	CcSEcCtD
Nedocromil—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00015	0.00228	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.00227	CcSEcCtD
Nedocromil—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.00227	CcSEcCtD
Nedocromil—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.00225	CcSEcCtD
Nedocromil—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000147	0.00223	CcSEcCtD
Nedocromil—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000145	0.00221	CcSEcCtD
Nedocromil—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000145	0.00221	CcSEcCtD
Nedocromil—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000145	0.0022	CcSEcCtD
Nedocromil—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000145	0.0022	CcSEcCtD
Nedocromil—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000145	0.0022	CcSEcCtD
Nedocromil—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000145	0.0022	CcSEcCtD
Nedocromil—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000144	0.00219	CcSEcCtD
Nedocromil—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000143	0.00217	CcSEcCtD
Nedocromil—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000143	0.00217	CcSEcCtD
Nedocromil—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000143	0.00217	CcSEcCtD
Nedocromil—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000142	0.00217	CcSEcCtD
Nedocromil—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000142	0.00216	CcSEcCtD
Nedocromil—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000142	0.00216	CcSEcCtD
Nedocromil—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000142	0.00216	CcSEcCtD
Nedocromil—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.00215	CcSEcCtD
Nedocromil—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000137	0.00209	CcSEcCtD
Nedocromil—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000137	0.00208	CcSEcCtD
Nedocromil—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000137	0.00208	CcSEcCtD
Nedocromil—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000135	0.00205	CcSEcCtD
Nedocromil—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000135	0.00205	CcSEcCtD
Nedocromil—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000135	0.00205	CcSEcCtD
Nedocromil—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000134	0.00204	CcSEcCtD
Nedocromil—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000132	0.00201	CcSEcCtD
Nedocromil—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000131	0.002	CcSEcCtD
Nedocromil—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000131	0.002	CcSEcCtD
Nedocromil—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000129	0.00196	CcSEcCtD
Nedocromil—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.00194	CcSEcCtD
Nedocromil—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000125	0.0019	CcSEcCtD
Nedocromil—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000125	0.0019	CcSEcCtD
Nedocromil—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000124	0.00189	CcSEcCtD
Nedocromil—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000123	0.00187	CcSEcCtD
Nedocromil—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000121	0.00184	CcSEcCtD
Nedocromil—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000121	0.00184	CcSEcCtD
Nedocromil—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000119	0.0018	CcSEcCtD
Nedocromil—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.0018	CcSEcCtD
Nedocromil—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000116	0.00177	CcSEcCtD
Nedocromil—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000116	0.00177	CcSEcCtD
Nedocromil—Rash—Formoterol—chronic obstructive pulmonary disease	0.000115	0.00176	CcSEcCtD
Nedocromil—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000115	0.00176	CcSEcCtD
Nedocromil—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000115	0.00175	CcSEcCtD
Nedocromil—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000115	0.00175	CcSEcCtD
Nedocromil—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000115	0.00174	CcSEcCtD
Nedocromil—Headache—Formoterol—chronic obstructive pulmonary disease	0.000115	0.00174	CcSEcCtD
Nedocromil—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000114	0.00174	CcSEcCtD
Nedocromil—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000114	0.00173	CcSEcCtD
Nedocromil—Rash—Montelukast—chronic obstructive pulmonary disease	0.000113	0.00172	CcSEcCtD
Nedocromil—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000113	0.00172	CcSEcCtD
Nedocromil—Headache—Montelukast—chronic obstructive pulmonary disease	0.000112	0.00171	CcSEcCtD
Nedocromil—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.00167	CcSEcCtD
Nedocromil—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000109	0.00166	CcSEcCtD
Nedocromil—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000109	0.00166	CcSEcCtD
Nedocromil—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000109	0.00165	CcSEcCtD
Nedocromil—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000109	0.00165	CcSEcCtD
Nedocromil—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000108	0.00165	CcSEcCtD
Nedocromil—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000107	0.00162	CcSEcCtD
Nedocromil—HSP90AA1—Integrins in angiogenesis—VEGFA—chronic obstructive pulmonary disease	0.000106	0.00199	CbGpPWpGaD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—CXCL8—chronic obstructive pulmonary disease	0.000105	0.00199	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000104	0.00196	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000104	0.00195	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000103	0.00194	CbGpPWpGaD
Nedocromil—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000103	0.00156	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by ERBB2—ERBB3—chronic obstructive pulmonary disease	0.000102	0.00193	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000102	0.00193	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—chronic obstructive pulmonary disease	9.94e-05	0.00187	CbGpPWpGaD
Nedocromil—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	9.92e-05	0.00151	CcSEcCtD
Nedocromil—HSP90AA1—Validated targets of C-MYC transcriptional activation—MMP9—chronic obstructive pulmonary disease	9.82e-05	0.00185	CbGpPWpGaD
Nedocromil—HSP90AA1—Corticotropin-releasing hormone—CXCL8—chronic obstructive pulmonary disease	9.61e-05	0.00181	CbGpPWpGaD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—NOS3—chronic obstructive pulmonary disease	9.6e-05	0.00181	CbGpPWpGaD
Nedocromil—FPR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	9.57e-05	0.0018	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	9.5e-05	0.00179	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—ERBB3—chronic obstructive pulmonary disease	9.41e-05	0.00177	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	9.36e-05	0.00176	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	9.3e-05	0.00175	CbGpPWpGaD
Nedocromil—PTGDR—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	9.24e-05	0.00174	CbGpPWpGaD
Nedocromil—HSP90AA1—Regulation of Telomerase—TGFB1—chronic obstructive pulmonary disease	9.12e-05	0.00172	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by VEGF—NOS3—chronic obstructive pulmonary disease	9.06e-05	0.00171	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	9.05e-05	0.00171	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	9.05e-05	0.00171	CbGpPWpGaD
Nedocromil—HSP90AA1—Regulation of Telomerase—EGFR—chronic obstructive pulmonary disease	8.95e-05	0.00169	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	8.94e-05	0.00169	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	8.86e-05	0.00167	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	8.74e-05	0.00165	CbGpPWpGaD
Nedocromil—HSP90AA1—EPH-Ephrin signaling—MMP9—chronic obstructive pulmonary disease	8.54e-05	0.00161	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	8.53e-05	0.00161	CbGpPWpGaD
Nedocromil—Pain—Prednisolone—chronic obstructive pulmonary disease	8.48e-05	0.00129	CcSEcCtD
Nedocromil—PTGDR—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	8.24e-05	0.00155	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—GSTP1—chronic obstructive pulmonary disease	8.23e-05	0.00155	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	8.14e-05	0.00153	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—APIP—chronic obstructive pulmonary disease	8.13e-05	0.00153	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	8.05e-05	0.00152	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	7.93e-05	0.00149	CbGpPWpGaD
Nedocromil—Urticaria—Prednisolone—chronic obstructive pulmonary disease	7.88e-05	0.0012	CcSEcCtD
Nedocromil—FPR1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	7.74e-05	0.00146	CbGpPWpGaD
Nedocromil—HSP90AA1—EPH-Ephrin signaling—VEGFA—chronic obstructive pulmonary disease	7.67e-05	0.00145	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	7.62e-05	0.00144	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	7.48e-05	0.00141	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	7.43e-05	0.0014	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	7.36e-05	0.00139	CbGpPWpGaD
Nedocromil—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	7.31e-05	0.00111	CcSEcCtD
Nedocromil—FPR1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	7.29e-05	0.00137	CbGpPWpGaD
Nedocromil—FPR1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	7.29e-05	0.00137	CbGpPWpGaD
Nedocromil—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	7.25e-05	0.00137	CbGpPWpGaD
Nedocromil—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	7.2e-05	0.0011	CcSEcCtD
Nedocromil—HSP90AA1—Corticotropin-releasing hormone—TGFB1—chronic obstructive pulmonary disease	7.16e-05	0.00135	CbGpPWpGaD
Nedocromil—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	7.16e-05	0.00135	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	7.14e-05	0.00135	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	7.08e-05	0.00134	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	7.04e-05	0.00133	CbGpPWpGaD
Nedocromil—PTGDR—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	7.04e-05	0.00133	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—RAPGEF3—chronic obstructive pulmonary disease	6.96e-05	0.00131	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	6.92e-05	0.0013	CbGpPWpGaD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—VEGFA—chronic obstructive pulmonary disease	6.92e-05	0.0013	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	6.86e-05	0.00129	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—LY96—chronic obstructive pulmonary disease	6.77e-05	0.00128	CbGpPWpGaD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—TNF—chronic obstructive pulmonary disease	6.69e-05	0.00126	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	6.68e-05	0.00126	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	6.67e-05	0.00126	CbGpPWpGaD
Nedocromil—HSP90AA1—Validated targets of C-MYC transcriptional activation—TP53—chronic obstructive pulmonary disease	6.66e-05	0.00126	CbGpPWpGaD
Nedocromil—Dizziness—Prednisolone—chronic obstructive pulmonary disease	6.56e-05	0.000997	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by VEGF—VEGFA—chronic obstructive pulmonary disease	6.53e-05	0.00123	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	6.48e-05	0.00122	CbGpPWpGaD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—TP53—chronic obstructive pulmonary disease	6.47e-05	0.00122	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	6.46e-05	0.00122	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	6.44e-05	0.00121	CbGpPWpGaD
Nedocromil—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	6.34e-05	0.000964	CcSEcCtD
Nedocromil—CYSLTR1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	6.27e-05	0.00118	CbGpPWpGaD
Nedocromil—Rash—Prednisolone—chronic obstructive pulmonary disease	6.25e-05	0.000951	CcSEcCtD
Nedocromil—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	6.25e-05	0.00095	CcSEcCtD
Nedocromil—Fatigue—Prednisone—chronic obstructive pulmonary disease	6.21e-05	0.000945	CcSEcCtD
Nedocromil—Headache—Prednisolone—chronic obstructive pulmonary disease	6.21e-05	0.000944	CcSEcCtD
Nedocromil—CYSLTR1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	6.2e-05	0.00117	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	6.07e-05	0.00114	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	6.05e-05	0.00114	CbGpPWpGaD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—IL6—chronic obstructive pulmonary disease	5.92e-05	0.00112	CbGpPWpGaD
Nedocromil—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	5.89e-05	0.000896	CcSEcCtD
Nedocromil—Nausea—Prednisolone—chronic obstructive pulmonary disease	5.89e-05	0.000895	CcSEcCtD
Nedocromil—CYSLTR2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	5.87e-05	0.00111	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	5.85e-05	0.0011	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	5.78e-05	0.00109	CbGpPWpGaD
Nedocromil—Urticaria—Prednisone—chronic obstructive pulmonary disease	5.72e-05	0.00087	CcSEcCtD
Nedocromil—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	5.7e-05	0.000866	CcSEcCtD
Nedocromil—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	5.7e-05	0.000866	CcSEcCtD
Nedocromil—CYSLTR2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.53e-05	0.00104	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	5.52e-05	0.00104	CbGpPWpGaD
Nedocromil—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	5.5e-05	0.00104	CbGpPWpGaD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—IL6—chronic obstructive pulmonary disease	5.4e-05	0.00102	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.38e-05	0.00101	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	5.33e-05	0.00101	CbGpPWpGaD
Nedocromil—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	5.31e-05	0.000807	CcSEcCtD
Nedocromil—HSP90AA1—Innate Immune System—TLR2—chronic obstructive pulmonary disease	5.28e-05	0.000995	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	5.24e-05	0.000989	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GC—chronic obstructive pulmonary disease	5.24e-05	0.000987	CbGpPWpGaD
Nedocromil—Asthenia—Prednisone—chronic obstructive pulmonary disease	5.17e-05	0.000786	CcSEcCtD
Nedocromil—PTGDR—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	5.15e-05	0.000971	CbGpPWpGaD
Nedocromil—HSP90AA1—Influenza Infection—TGFB1—chronic obstructive pulmonary disease	5.09e-05	0.00096	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	5.05e-05	0.000952	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	5.03e-05	0.000948	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—KL—chronic obstructive pulmonary disease	4.96e-05	0.000936	CbGpPWpGaD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	4.96e-05	0.000935	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.96e-05	0.000934	CbGpPWpGaD
Nedocromil—HSP90AA1—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	4.95e-05	0.000933	CbGpPWpGaD
Nedocromil—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	4.93e-05	0.00075	CcSEcCtD
Nedocromil—HSP90AA1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.87e-05	0.000918	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.79e-05	0.000902	CbGpPWpGaD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—IL6—chronic obstructive pulmonary disease	4.78e-05	0.000902	CbGpPWpGaD
Nedocromil—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.76e-05	0.000724	CcSEcCtD
Nedocromil—CYSLTR1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	4.75e-05	0.000896	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.59e-05	0.000865	CbGpPWpGaD
Nedocromil—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.58e-05	0.000697	CcSEcCtD
Nedocromil—FPR1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	4.57e-05	0.000862	CbGpPWpGaD
Nedocromil—Rash—Prednisone—chronic obstructive pulmonary disease	4.54e-05	0.000691	CcSEcCtD
Nedocromil—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.54e-05	0.00069	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by VEGF—IL6—chronic obstructive pulmonary disease	4.52e-05	0.000851	CbGpPWpGaD
Nedocromil—Headache—Prednisone—chronic obstructive pulmonary disease	4.51e-05	0.000686	CcSEcCtD
Nedocromil—HSP90AA1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	4.5e-05	0.000848	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.48e-05	0.000844	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—EGFR—chronic obstructive pulmonary disease	4.45e-05	0.000838	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	4.42e-05	0.000833	CbGpPWpGaD
Nedocromil—Nausea—Prednisone—chronic obstructive pulmonary disease	4.28e-05	0.000651	CcSEcCtD
Nedocromil—HSP90AA1—Cellular responses to stress—CXCL8—chronic obstructive pulmonary disease	4.14e-05	0.000779	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.12e-05	0.000776	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.09e-05	0.000771	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—EGFR—chronic obstructive pulmonary disease	4.09e-05	0.000771	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.07e-05	0.000767	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.04e-05	0.000762	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4e-05	0.000755	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.98e-05	0.00075	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.95e-05	0.000744	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.83e-05	0.000722	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.83e-05	0.000722	CbGpPWpGaD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	3.81e-05	0.000719	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—LEP—chronic obstructive pulmonary disease	3.77e-05	0.000711	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.76e-05	0.000708	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.74e-05	0.000705	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	3.72e-05	0.000701	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.72e-05	0.0007	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.64e-05	0.000685	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.61e-05	0.000681	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.59e-05	0.000676	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.58e-05	0.000674	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.5e-05	0.00066	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.47e-05	0.000653	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.45e-05	0.000651	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—IL6—chronic obstructive pulmonary disease	3.42e-05	0.000644	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.41e-05	0.000643	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—CRP—chronic obstructive pulmonary disease	3.4e-05	0.000641	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—VEGFA—chronic obstructive pulmonary disease	3.36e-05	0.000633	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.32e-05	0.000627	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—TLR4—chronic obstructive pulmonary disease	3.26e-05	0.000615	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.21e-05	0.000605	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.18e-05	0.000599	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—MMP9—chronic obstructive pulmonary disease	3.18e-05	0.000598	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—IL6—chronic obstructive pulmonary disease	3.14e-05	0.000592	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.12e-05	0.000588	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.1e-05	0.000584	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—TLR2—chronic obstructive pulmonary disease	3.07e-05	0.00058	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—KL—chronic obstructive pulmonary disease	2.89e-05	0.000545	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—HDAC2—chronic obstructive pulmonary disease	2.87e-05	0.000541	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.86e-05	0.000539	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—VEGFA—chronic obstructive pulmonary disease	2.85e-05	0.000537	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.83e-05	0.000534	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.83e-05	0.000533	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.82e-05	0.000531	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.8e-05	0.000528	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.75e-05	0.000518	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.73e-05	0.000515	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.71e-05	0.000511	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—KL—chronic obstructive pulmonary disease	2.67e-05	0.000503	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.64e-05	0.000498	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.61e-05	0.000492	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.6e-05	0.000491	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.58e-05	0.000486	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—EGFR—chronic obstructive pulmonary disease	2.57e-05	0.000484	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—TP53—chronic obstructive pulmonary disease	2.54e-05	0.000478	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.52e-05	0.000475	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.52e-05	0.000475	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.49e-05	0.000469	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.41e-05	0.000453	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.4e-05	0.000453	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.38e-05	0.000448	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CD8A—chronic obstructive pulmonary disease	2.33e-05	0.000439	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—IL6—chronic obstructive pulmonary disease	2.32e-05	0.000438	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—MMP9—chronic obstructive pulmonary disease	2.27e-05	0.000427	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.21e-05	0.000416	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—ERBB3—chronic obstructive pulmonary disease	2.17e-05	0.000408	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.16e-05	0.000408	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.15e-05	0.000405	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.13e-05	0.000402	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.1e-05	0.000396	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.07e-05	0.000391	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	2.03e-05	0.000383	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.03e-05	0.000382	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.01e-05	0.000379	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—ERBB3—chronic obstructive pulmonary disease	2e-05	0.000377	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2e-05	0.000377	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.98e-05	0.000374	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CRP—chronic obstructive pulmonary disease	1.98e-05	0.000373	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.98e-05	0.000373	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—IL6—chronic obstructive pulmonary disease	1.97e-05	0.000372	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.96e-05	0.00037	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.96e-05	0.000369	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.95e-05	0.000368	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.93e-05	0.000364	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—TLR4—chronic obstructive pulmonary disease	1.9e-05	0.000358	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.89e-05	0.000356	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.88e-05	0.000354	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.87e-05	0.000352	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	1.87e-05	0.000352	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—EGFR—chronic obstructive pulmonary disease	1.83e-05	0.000345	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.82e-05	0.000343	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.79e-05	0.000338	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.75e-05	0.000329	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.74e-05	0.000329	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.73e-05	0.000327	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.73e-05	0.000326	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.72e-05	0.000325	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.67e-05	0.000316	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—NOS2—chronic obstructive pulmonary disease	1.67e-05	0.000314	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.65e-05	0.00031	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—EGFR—chronic obstructive pulmonary disease	1.62e-05	0.000305	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.61e-05	0.000304	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.59e-05	0.0003	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.59e-05	0.0003	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.56e-05	0.000294	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.54e-05	0.000291	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.51e-05	0.000285	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.44e-05	0.000271	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—TP53—chronic obstructive pulmonary disease	1.42e-05	0.000268	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.41e-05	0.000265	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—SERPINE1—chronic obstructive pulmonary disease	1.4e-05	0.000265	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.4e-05	0.000264	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.37e-05	0.000258	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.36e-05	0.000256	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.36e-05	0.000256	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.35e-05	0.000254	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—NOS3—chronic obstructive pulmonary disease	1.34e-05	0.000253	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.31e-05	0.000247	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.31e-05	0.000247	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.25e-05	0.000236	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.25e-05	0.000235	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—IL6—chronic obstructive pulmonary disease	1.24e-05	0.000234	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.24e-05	0.000234	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL1B—chronic obstructive pulmonary disease	1.24e-05	0.000233	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.22e-05	0.000231	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.2e-05	0.000226	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ALB—chronic obstructive pulmonary disease	1.17e-05	0.000221	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.16e-05	0.000219	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.12e-05	0.000212	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.1e-05	0.000208	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.05e-05	0.000198	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.03e-05	0.000194	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.84e-06	0.000185	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.43e-06	0.000178	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—EGFR—chronic obstructive pulmonary disease	9.42e-06	0.000178	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.41e-06	0.000177	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.39e-06	0.000177	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—TGFB1—chronic obstructive pulmonary disease	8.87e-06	0.000167	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—EGFR—chronic obstructive pulmonary disease	8.7e-06	0.000164	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.65e-06	0.000163	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.48e-06	0.00016	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.33e-06	0.000157	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.54e-06	0.000142	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL6—chronic obstructive pulmonary disease	7.24e-06	0.000136	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.12e-06	0.000134	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.77e-06	0.000128	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—IL6—chronic obstructive pulmonary disease	6.68e-06	0.000126	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.52e-06	0.000123	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.21e-06	0.000117	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.09e-06	0.000115	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.11e-06	9.64e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.68e-06	8.82e-05	CbGpPWpGaD
